Home
GMED
GMED News

Latest Globus Medical Inc. (GMED) News on March 29, 2025

Despite the downward trend in earnings at Globus Medical (NYSE:GMED) the stock grows 7.0%, bringing five-year gains to 80%

Simply Wall St.

3 days ago

Despite the downward trend in earnings at Globus Medical (NYSE:GMED) the stock grows 7.0%, bringing five-year gains to 80%

Argus Research

4 days ago

GMED: Raising target price to $84.00

1 Healthcare Stock with Solid Fundamentals and 2 to Turn Down

StockStory

8 days ago

1 Healthcare Stock with Solid Fundamentals and 2 to Turn Down

GMED Stock Jumps 41.8% in a Year: What's Behind the Rally?

Zacks

8 days ago

GMED Stock Jumps 41.8% in a Year: What's Behind the Rally?

Should You Hold Globus Medical Stock in Your Portfolio Now?

Zacks

10 days ago

Should You Hold Globus Medical Stock in Your Portfolio Now?

New Product Launches Benefit GMED Stock Amid Macro Issues

Zacks

11 days ago

New Product Launches Benefit GMED Stock Amid Macro Issues

MT Newswires

11 days ago

Truist Cuts Price Target on Globus Medical to $82 From $90, Keeps Hold Rating

Globus Medical Expands Anterior Spine Portfolio With Two New Offerings

Zacks

15 days ago

Globus Medical Expands Anterior Spine Portfolio With Two New Offerings

Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades

GlobeNewswire

18 days ago

Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades

Medical Devices & Supplies - Specialty Stocks Q4 In Review: Globus Medical (NYSE:GMED) Vs Peers

StockStory

18 days ago

Medical Devices & Supplies - Specialty Stocks Q4 In Review: Globus Medical (NYSE:GMED) Vs Peers

Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting

GlobeNewswire

23 days ago

Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting

Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference

GlobeNewswire

24 days ago

Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference

Is the Options Market Predicting a Spike in Globus Medical (GMED) Stock?

Zacks

24 days ago

Is the Options Market Predicting a Spike in Globus Medical (GMED) Stock?

Globus Medical's (NYSE:GMED) Soft Earnings Don't Show The Whole Picture

Simply Wall St.

24 days ago

Globus Medical's (NYSE:GMED) Soft Earnings Don't Show The Whole Picture

Is Globus Medical, Inc. (GMED) the Best Medical Technology Stock to Buy According to Analysts?

Insider Monkey

24 days ago

Is Globus Medical, Inc. (GMED) the Best Medical Technology Stock to Buy According to Analysts?

Argus Research

25 days ago

GMED: Lowering target price to $82.00

MT Newswires

25 days ago

Globus Medical Insider Sold Shares Worth $590,100, According to a Recent SEC Filing

Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results

PR Newswire

25 days ago

Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results

1 Mid-Cap Stock to Target This Week and 2 to Avoid

StockStory

25 days ago

1 Mid-Cap Stock to Target This Week and 2 to Avoid

Argus Research

a month ago

GMED: Lowering target price to $84.00

Is Globus Medical, Inc. (NYSE:GMED) Trading At A 32% Discount?

Simply Wall St.

a month ago

Is Globus Medical, Inc. (NYSE:GMED) Trading At A 32% Discount?

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Zacks

a month ago

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Globus Medical Q4 Earnings & Revenues Top, Margins Expand, Stock Dips

Zacks

a month ago

Globus Medical Q4 Earnings & Revenues Top, Margins Expand, Stock Dips

Globus Medical Inc (GMED) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...

GuruFocus.com

a month ago

Globus Medical Inc (GMED) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...

Globus Medical (GMED) Q4 2024 Earnings Call Transcript

Motley Fool

a month ago

Globus Medical (GMED) Q4 2024 Earnings Call Transcript

Globus Medical (GMED) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks

a month ago

Globus Medical (GMED) Reports Q4 Earnings: What Key Metrics Have to Say

Globus Medical (GMED) Q4 Earnings and Revenues Top Estimates

Zacks

a month ago

Globus Medical (GMED) Q4 Earnings and Revenues Top Estimates

Associated Press Finance

a month ago

Globus Medical: Q4 Earnings Snapshot

Globus Medical’s (NYSE:GMED) Q4 Sales Beat Estimates

StockStory

a month ago

Globus Medical’s (NYSE:GMED) Q4 Sales Beat Estimates

MT Newswires

a month ago

Globus Medical Q4 Non-GAAP EPS, Net Sales Increase

Globus Medical Reports Fourth Quarter and Full Year 2024 Results

GlobeNewswire

a month ago

Globus Medical Reports Fourth Quarter and Full Year 2024 Results

Globus Medical (GMED) Q4 Earnings: What To Expect

StockStory

a month ago

Globus Medical (GMED) Q4 Earnings: What To Expect

Argus Research

a month ago

GMED: Raising target price to $89.00

Si-Bone (SIBN) Expected to Beat Earnings Estimates: Should You Buy?

Zacks

a month ago

Si-Bone (SIBN) Expected to Beat Earnings Estimates: Should You Buy?

Globus Medical (GMED) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Zacks

a month ago

Globus Medical (GMED) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

DexCom (DXCM) Misses Q4 Earnings Estimates

Zacks

a month ago

DexCom (DXCM) Misses Q4 Earnings Estimates

Globus Medical (GMED) Reports Next Week: Wall Street Expects Earnings Growth

Zacks

a month ago

Globus Medical (GMED) Reports Next Week: Wall Street Expects Earnings Growth

Globus Medical Inks $250M Deal to Acquire Nevro: Stock to Gain?

Zacks

2 months ago

Globus Medical Inks $250M Deal to Acquire Nevro: Stock to Gain?

Globus Medical strengthens SCS market position with $250m Nevro deal

Medical Device Network

2 months ago

Globus Medical strengthens SCS market position with $250m Nevro deal

Globus Medical to acquire Nevro for $5.85 per share

TipRanks

2 months ago

Globus Medical to acquire Nevro for $5.85 per share

Globus Medical to Acquire Nevro in $250 Million Deal to Expand Chronic Pain Treatment Portfolio

GuruFocus.com

2 months ago

Globus Medical to Acquire Nevro in $250 Million Deal to Expand Chronic Pain Treatment Portfolio

Globus to buy Nevro for $250M

MedTech Dive

2 months ago

Globus to buy Nevro for $250M

MT Newswires

2 months ago

Globus Medical to Acquire Nevro

Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients

GlobeNewswire

2 months ago

Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients

Dentsply Sirona Appoints Michael Barber and Daniel Scavilla as New Board Members

GlobeNewswire

2 months ago

Dentsply Sirona Appoints Michael Barber and Daniel Scavilla as New Board Members

Globus Medical (GMED) is a Top-Ranked Growth Stock: Should You Buy?

Zacks

2 months ago

Globus Medical (GMED) is a Top-Ranked Growth Stock: Should You Buy?

Argus Research

2 months ago

GMED: Lowering target price to $97.00

Globus Medical Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call

GlobeNewswire

2 months ago

Globus Medical Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call

Argus Research

2 months ago

GMED: Raising target price to $98.00

Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term

Zacks

2 months ago

Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term

Argus Research

2 months ago

GMED: Raising target price to $97.00

Globus Medical Surges 62.1% in a Year: What's Driving the Stock?

Zacks

2 months ago

Globus Medical Surges 62.1% in a Year: What's Driving the Stock?

Will Globus Medical (GMED) Beat Estimates Again in Its Next Earnings Report?

Zacks

2 months ago

Will Globus Medical (GMED) Beat Estimates Again in Its Next Earnings Report?

Here's Why Globus Medical (GMED) is a Strong Growth Stock

Zacks

2 months ago

Here's Why Globus Medical (GMED) is a Strong Growth Stock

Argus Research

2 months ago

GMED: Raising target price to $93.00

MT Newswires

2 months ago

Globus Medical Insider Sold Shares Worth $1,250,770, According to a Recent SEC Filing

Outlook For These Biotechs Brightens As FDA Ushers In New Rules For Sector

Investor's Business Daily

3 months ago

Outlook For These Biotechs Brightens As FDA Ushers In New Rules For Sector

These Oil And Gas Names Hit Highs As Energy Prices Jump

Investor's Business Daily

3 months ago

These Oil And Gas Names Hit Highs As Energy Prices Jump

GMED Stock Rides on NuVasive Synergy Benefits Amid Macro Issues

Zacks

3 months ago

GMED Stock Rides on NuVasive Synergy Benefits Amid Macro Issues

Globus Medical upgraded to Neutral from Underperform at BofA

TipRanks

3 months ago

Globus Medical upgraded to Neutral from Underperform at BofA

MT Newswires

3 months ago

Globus Medical Reports Preliminary Q4 Sales, Sets 2025 Guidance

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

GlobeNewswire

3 months ago

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Zacks

3 months ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Globus Medical Stock Revs Up For Next Move After 70% Run

Investor's Business Daily

3 months ago

Globus Medical Stock Revs Up For Next Move After 70% Run

Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term

Zacks

3 months ago

Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term

4 Healthcare Stocks Rising More Than 50% in 2024 With Room to Grow

Zacks

3 months ago

4 Healthcare Stocks Rising More Than 50% in 2024 With Room to Grow

Reasons to Add GMED Stock to Your Portfolio Right Now

Zacks

3 months ago

Reasons to Add GMED Stock to Your Portfolio Right Now

Argus Research

3 months ago

GMED: Lowering target price to $87.00

Is Your Portfolio Missing These 5 High-Growth Healthcare Stocks?

Zacks

3 months ago

Is Your Portfolio Missing These 5 High-Growth Healthcare Stocks?

Reasons to Ratain CVS Stock in Your Portfolio Now

Zacks

3 months ago

Reasons to Ratain CVS Stock in Your Portfolio Now

Reasons to Retain ABT Stock in Your Portfolio Now

Zacks

3 months ago

Reasons to Retain ABT Stock in Your Portfolio Now

Globus Medical price target raised to $90 from $85 at Truist

TipRanks

3 months ago

Globus Medical price target raised to $90 from $85 at Truist

MT Newswires

3 months ago

Truist Securities Adjusts Price Target on Globus Medical to $90 From $85, Keeps Hold Rating

MT Newswires

3 months ago

RBC Raises Price Target on Globus Medical to $101 From $92, Keeps Outperform Rating

Argus Research

3 months ago

GMED: Raising target price to $88.00

Reasons to Retain STE Stock in Your Portfolio Now

Zacks

3 months ago

Reasons to Retain STE Stock in Your Portfolio Now

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Zacks

3 months ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Baxter Stock May Gain Following Five New Injectable Product Launches

Zacks

4 months ago

Baxter Stock May Gain Following Five New Injectable Product Launches

Reasons to Retain Alcon Stock in Your Portfolio for Now

Zacks

4 months ago

Reasons to Retain Alcon Stock in Your Portfolio for Now

Reasons to Retain PacBio Stock in Your Portfolio for Now

Zacks

4 months ago

Reasons to Retain PacBio Stock in Your Portfolio for Now

MBOT Stock Gains Following FDA Submission of the LIBERTY System

Zacks

4 months ago

MBOT Stock Gains Following FDA Submission of the LIBERTY System

Reasons to Retain Envista Stock in Your Portfolio for Now

Zacks

4 months ago

Reasons to Retain Envista Stock in Your Portfolio for Now

The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen

Zacks

4 months ago

The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen

Inari Medical Stock Gets RS Rating Upgrade

Investor's Business Daily

4 months ago

Inari Medical Stock Gets RS Rating Upgrade

NSPR Stock May Gain as First Patient Enrolls in CGUARDIANS II Study

Zacks

4 months ago

NSPR Stock May Gain as First Patient Enrolls in CGUARDIANS II Study

5 Medical Device Stocks That Survived the 2024 Market Volatility

Zacks

4 months ago

5 Medical Device Stocks That Survived the 2024 Market Volatility

Argus Research

4 months ago

GMED: Lowering target price to $87.00

ANGO Stock Up Post FDA Nod for Prostate Tissue Ablation With NanoKnife

Zacks

4 months ago

ANGO Stock Up Post FDA Nod for Prostate Tissue Ablation With NanoKnife

ZYXI Stock Gains on the Completion of NiCO's Clinical Verification Trial

Zacks

4 months ago

ZYXI Stock Gains on the Completion of NiCO's Clinical Verification Trial

Cooper Companies Q4 Earnings Beat, Revenues Miss, Stock Falls

Zacks

4 months ago

Cooper Companies Q4 Earnings Beat, Revenues Miss, Stock Falls

Reasons to Retain ZBH Stock in Your Portfolio for Now

Zacks

4 months ago

Reasons to Retain ZBH Stock in Your Portfolio for Now

Reasons to Retain TNDM Stock in Your Portfolio for Now

Zacks

4 months ago

Reasons to Retain TNDM Stock in Your Portfolio for Now

What Makes Globus Medical (GMED) a New Buy Stock

Zacks

4 months ago

What Makes Globus Medical (GMED) a New Buy Stock

GEHC Stock May Gain Following the Launches of Aurora and Clarify DL

Zacks

4 months ago

GEHC Stock May Gain Following the Launches of Aurora and Clarify DL

Globus Medical (GMED) Up 2.1% Since Last Earnings Report: Can It Continue?

Zacks

4 months ago

Globus Medical (GMED) Up 2.1% Since Last Earnings Report: Can It Continue?

PDCO Stock Gains Despite Q2 Earnings Miss and Lower Margins

Zacks

4 months ago

PDCO Stock Gains Despite Q2 Earnings Miss and Lower Margins

GEHC Stock May Gain From Potential FDA Clearance for CleaRecon DL

Zacks

4 months ago

GEHC Stock May Gain From Potential FDA Clearance for CleaRecon DL

Reasons to Retain EYE Stock in Your Portfolio for Now

Zacks

4 months ago

Reasons to Retain EYE Stock in Your Portfolio for Now

Argus Research

4 months ago

GMED: What does Argus have to say about GMED?

Novocure Stock Earns 96 RS Rating

Investor's Business Daily

4 months ago

Novocure Stock Earns 96 RS Rating

Share on Social Networks: